Skip to main content
OpenTrials
Completed

NCT Number: NCT04913714

10+10+30 Infant Vaccines Communication Via Radio in Ethiopia

A cohort study to investigate the effectiveness of radio intervention comprising 10-minute of drama, 10-minute of discussion led by community extension workers, and 30-minute phone-in from listeners on childhood vaccination coverage and timeliness

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

1 day–5 week

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Jimma University, Jimma, Ethiopia

Loading trial locations.

About this study

The evaluation is conducted in 2 districts located in the Oromia region of Ethiopia. One of the districts will be allocated to receive the 3-month radio intervention while the other district that will not have access to the radio intervention will serve as the control.

Data collection includes survey of mothers at two "key" times: at baseline (when infants are at most 5 weeks old; but before beginning the intervention) and at endline (including examination of infant vaccination records) at most 21 days after the end of the radio intervention. The same mothers and infants to be followed at endline.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Mother, with infant of at most 5 weeks old; Lives in the study district; Consents to participate in study

Exclusion criteria

Mother, with infant of more than 5 weeks old; Does not live in study district; Does not consent to participate in study

Treatment and study plan

3-month radio intervention on infant vaccination

Behavioral

Radio intervention comprising 10-minute drama, 10-minute discussion of the drama by trained health extension workers and 30-minute phone-in from listeners

Primary outcomes

  1. Penta 3 vaccine coverage of infant

    Time frame: up to 3 weeks after the intervention ends

    Infant's vaccination record or mother's recall based on interviewer-administered questionnaire

Secondary outcomes

  1. Timeliness of infant vaccines

    Time frame: up to 3 weeks after the intervention ends

    Infant's vaccination record or mother's recall based on interviewer-administered questionnaire

  2. Full coverage of infant vaccines

    Time frame: up to 3 weeks after the intervention ends

    Infant's vaccination record or mother's recall based on a questionnaire

  3. Perceived barriers to vaccination

    Time frame: Immediately before intervention starts, and up to 3 weeks after the intervention ends

    Mother completes interviewer-administered questionnaire at specified times

  4. Perceived susceptibility to vaccine-preventable diseases in children

    Time frame: Immediately before intervention starts, and up to 3 weeks after the intervention ends

    Mother completes interviewer-administered questionnaire at specified times

  5. Perceived benefits of infant vaccines

    Time frame: Immediately before intervention starts, and up to 3 weeks after the intervention ends

    Mother completes interviewer-administered questionnaire at specified times

  6. Perceived severity of vaccine-preventable diseases in children

    Time frame: Immediately before intervention starts, and up to 3 weeks after the intervention ends

    Mother completes interviewer-administered questionnaire at specified times

  7. Cues to action

    Time frame: Immediately before intervention starts, and up to 3 weeks after the intervention ends

    Mother completes interviewer-administered questionnaire at specified times

Sponsors and collaborators

Lead sponsor

Syracuse University

Other

Collaborators

  • Bill and Melinda Gates Foundation
  • Jimma University
  • Texas A&M University

Registry information

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Jun 4, 2021
Registry last updated
Jun 4, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.